In patients hospitalized with severe scrub typhus, outcomes were better with a combination of doxycycline and azithromycin than with either drug alone.
Scrub typhus is endemic to Southeast and South Asia and Northern Australia and typically presents with fever, headache, altered sensorium, rash (including an eschar), and thrombocytopenia. Most cases are acquired in rural areas, where the transmitting mite is most common. For patients who develop severe scrub typhus, which is characterized by multiorgan dysfunction, the optimal therapy is not known. Therefore, investigators conducted a randomized trial to compare 7 days of intravenous doxycycline, azithromycin, or both in 794 patients hospitalized in India with severe scrub typhus.
Participants were severely ill at enrollment: Complications included respiratory (62%), hepatic (54%), cardiovascular (42%), renal (30%), and neurologic (20%) dys…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)